What is the typical treatment for intermittent asthma?

The typical treatment for intermittent asthma involves the use of a short-acting beta agonist (SABA) as needed. SABA medications, such as albuterol, are effective bronchodilators that quickly relieve symptoms of asthma by relaxing the smooth muscles in the airways, leading to immediate improvement in airflow. This on-demand approach is appropriate for intermittent asthma, where symptoms are infrequent and typically arise in response to specific triggers.

In patients with intermittent asthma, the goal is to manage acute symptoms without needing daily medication. Regular use of a SABA aligns with the management guidelines for this classification of asthma, as it allows for control of symptoms while minimizing potential side effects and complications associated with long-term medication use.

While other options, such as daily low-dose inhaled corticosteroids or high-dose inhaled corticosteroids, and long-acting beta agonists may be appropriate for more persistent forms of asthma, they are not necessary for individuals classified as having intermittent asthma, where control can be maintained through occasional SABA use.